research use only
Cat.No.S4821
| Related Targets | Adrenergic Receptor AChR 5-HT Receptor COX Calcium Channel Histamine Receptor Dopamine Receptor GABA Receptor TRP Channel Cholinesterase (ChE) |
|---|---|
| Other iGluR Inhibitors | tat-nr2b9c |
|
In vitro |
Water : 15 mg/mL
DMSO
: Insoluble
|
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 75.07 | Formula | C2H5NO2 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 56-40-6 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | 2-Aminoacetic acid, Aminoacetic acid, Glycocoll | SMILES | C(C(=O)O)N | ||
Read more about storage stability stock solution CAS number SMILES
| Targets/IC50/Ki |
MT2 receptor
9.8(pKi)
MT1 receptor
9.45(pKi)
|
|---|---|
| In vitro |
Glycine significantly increases the MG-63 cell proliferation in a dosedependent manner. Activity of alkaline phosphatase (ALP) and phosphorylation of extracellular-signal-regulated kinase are increased by this compound in MG-63 cells. It also increases the BrdU-incorporation and Ki-67 mRNA expression in MCF-7 cells, induces the up-regulation of estrogen receptor-β mRNA expression and estrogen response element-luciferase activity in MG-63 and MCF-7 cells.
|
| In vivo |
Glycine is the most abundant amino acid in the body and is involved in multiple metabolic pathways. Circulating levels of this compound in humans, rats and mice, cats, and dogs range from 0.2-0.4 mM. In rabbits and pigs, they are 1-1.5 mM. Intracellular concentrations are much higher, particularly in renal proximal tubules, which reabsorb filtered glycine and reach 4–10x circulating levels depending on whether they are being actively perfused. It has been reported to lower blood pressure in an NMDA-sensitive fashion. This amino acid has an estrogen-like osteoprotective effect in menopause models. It significantly increases the ALP activity, enhances bone mineral density, trabecular number, and connectivity density in OVX mice.
|
References |
|
(data from https://clinicaltrials.gov, updated on 2025-12-11)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06083480 | RECRUITING | Osteoarthritis, Knee; Total Knee Arthroplasty; Chronic Postsurgical Pain |
Vanderbilt University Medical Center |
2024-12-06 | PHASE4 |
| NCT04738422 | ENROLLING_BY_INVITATION | Airway Disease |
Indiana University |
2020-09-11 | PHASE2 |
| NCT07285135 | NOT_YET_RECRUITING | Metabolic Dysfunction Associated Fatty Liver Disease |
Singapore General Hospital |
2025-12 | |
| NCT06959251 | RECRUITING | Primary Ciliary Dyskinesia |
Instituto Nacional de Enfermedades Respiratorias |
2025-10-02 | |
| NCT07575984 | RECRUITING | Ischemic Stroke |
Pharmasoft |
2025-11-04 | PHASE4 |
| NCT07140146 | RECRUITING | Peri-implant Mucositis |
University of Pavia |
2025-08-30 |
Read more about Clinical Trials
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.